Cargando…
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
In adrenoleukodystrophy (ALD), contrast enhancement (CE) is a disease activity marker, but there is uncertainty about the optimal delay, if any, between contrast injection and magnetic resonance imaging (MRI) acquisition to avoid false-negative results. We acquired axial two-dimensional (2D) and thr...
Autores principales: | Moscatelli, Marco, Benzoni, Chiara, Doniselli, Fabio M., Verri, Mattia, Pascuzzo, Riccardo, Aquino, Domenico, Mazzi, Federica, Erbetta, Alessandra, Salsano, Ettore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545606/ https://www.ncbi.nlm.nih.gov/pubmed/37782421 http://dx.doi.org/10.1186/s41747-023-00373-6 |
Ejemplares similares
-
Pain Study in X-Linked Adrenoleukodystrophy in Males and Females
por: Bachiocco, Valeria, et al.
Publicado: (2021) -
Childhood cerebral adrenoleukodystrophy
por: Mittal, Aliza, et al.
Publicado: (2014) -
Adult‐onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?
por: Salsano, Ettore, et al.
Publicado: (2022) -
Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
por: Orchard, Paul J, et al.
Publicado: (2011) -
Muscle quantitative MRI in adult SMA patients on nusinersen treatment: a longitudinal study
por: Gallone, Annamaria, et al.
Publicado: (2022)